Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review-Reference-Cited by-同舟云学术

Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review

Published:2023-08 Issue:8 Volume:43 Page:579-593
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Corominas Héctor^ORCID,Young David,Cummings J. R. Fraser,Bouhnik Yoram,Armuzzi Alessandro,Thaci Diamant,Kim Jihyun

Funder

Samsung Bioepis

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-023-01284-5.pdf

Reference31 articles.

1. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370(9602):1861–74.

2. Mehta P, Manson JJ. What is the clinical relevance of TNF inhibitor immunogenicity in the management of patients with rheumatoid arthritis? Front Immunol. 2020;11:589.

3. Pelechas E, Drosos AA. Etanercept biosimilar SB-4. Expert Opin Biol Ther. 2019;19(3):173–9.

4. Emery P, Vencovský J, Sylwestrzak A, et al. 52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis. Rheumatology. 2017;56(12):2093–101.

5. Gisbert JP, Gaffney K, Young D, Ebbers HC, Girolomoni G. Current evidence on the use of the adalimumab biosimilar SB5 (Imraldi): a multidisciplinary perspective. Expert Opin Biol Ther. 2022 (just-accepted).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of Biosimilars in the Management of Patients with Inflammatory Bowel Disease: An International Survey;Journal of Clinical Medicine;2024-05-24

2. Advancing injection force modeling and viscosity-dependent injectability evaluation for prefilled syringes;European Journal of Pharmaceutics and Biopharmaceutics;2024-04